Document Detail

Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus.
MedLine Citation:
PMID:  6235618     Owner:  NLM     Status:  MEDLINE    
Fusarium sp. contaminated feedstuffs elicit adverse estrogenic effects in several commercially important animal species via the mycotoxin zearalenone. An estrogenically active synthetic derivative, zearalanol, is used as an anabolic agent in cattle. Since estrogens can irreversibly alter target tissue development, we investigated the estrogenic activity of these compounds in the neonatal rat uterus. Both induced dose-dependent premature uterine growth when injected daily on postnatal days 1-5 (ED50 = 1.3 mg/kg BW). Nuclear estrogen receptor levels dramatically increased 1 hour after either a single injection on day 5 or after five daily injections. In 5-day-old animals, the translocated nuclear receptor was characterized as a single class of binding sites with a dissociation constant (KD) for estradiol (E2) of 1 nM. At 15 days, zearalanol-treated animals showed greater uterine nuclear receptor retention than zearalenone-treated animals. In 5-day-old animals, single mycotoxin doses induced five fold elevations of ornithine decarboxylase (ODC) at 6 hours. Unlike the growth response, ODC dose-response studies showed zearalanol to be about 20-fold more effective than zearalenone. Time course studies revealed that a low dose of zearalenone, but not of zearalanol, resulted in a shift in peak activity from 6 to 8 hours. These data suggest that metabolism of zearalenone may be important in short-term pharmacodynamics. In a competitive binding assay, neither compound competed [3H]E2 from the E2 binding site on alpha-fetoprotein. We conclude that the uterine growth response and ODC induction demonstrate the neonatal estrogenic action of these mycotoxins, apparently mediated via the estrogen receptor. The greater effectiveness of zearalanol in inducing ODC may be related to nuclear retention and/or zearalenone metabolism.
D M Sheehan; W S Branham; K L Medlock; E R Shanmugasundaram
Related Documents :
11999068 - Detecting endocrine-disrupting compounds by fast impedance measurements.
18052088 - On the intractability of estrogen-related receptor alpha as a target for activation by ...
6313258 - Hormone receptors in dystrophic and neoplastic vulvar disease. preliminary considerations.
25466648 - The angiopoietin/tie receptor system: focusing its role for ischemia-reperfusion injury.
21827738 - Impedance measurement: a new method to detect ligand-biased receptor signaling.
15932618 - Mice lacking dopamine d1 receptors express normal lithium chloride-induced conditioned ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Teratology     Volume:  29     ISSN:  0040-3709     ISO Abbreviation:  Teratology     Publication Date:  1984 Jun 
Date Detail:
Created Date:  1984-09-05     Completed Date:  1984-09-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0153257     Medline TA:  Teratology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  383-92     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn*
Enzyme Induction / drug effects
Organ Size / drug effects
Ornithine Decarboxylase / biosynthesis,  metabolism
Receptors, Estrogen / drug effects,  metabolism
Resorcinols / pharmacology*
Uterus / drug effects*,  enzymology,  growth & development,  metabolism
Zearalenone / metabolism,  pharmacology*
Zeranol / metabolism,  pharmacology*
Reg. No./Substance:
0/Receptors, Estrogen; 0/Resorcinols; 17924-92-4/Zearalenone; 26538-44-3/Zeranol; EC Decarboxylase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidemiological study of gastroschisis and omphalocele in Spain.
Next Document:  Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and pa...